The effects of marijuana smoking on lung function in older people

Author:

Tan Wan C.,Bourbeau JeanORCID,Aaron Shawn D.,Hogg James C.,Maltais François,Hernandez Paul,Marciniuk Darcy D.,Chapman Kenneth R.ORCID,To Teresa,FitzGerald J. Mark,Walker Brandie L.,Road Jeremy,Zheng Liyun,Zhou Guohai,Yau Trevor,Benedetti Andrea,O'Donnell DenisORCID,Sin Don D.

Abstract

BackgroundPrevious studies have associated marijuana exposure with increased respiratory symptoms and chronic bronchitis among long-term cannabis smokers. The long-term effects of smoked marijuana on lung function remain unclear.MethodsWe determined the association of marijuana smoking with the risk of spirometrically defined chronic obstructive pulmonary disease (COPD) (post-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity ratio <0.7) in 5291 population-based individuals and the rate of decline in FEV1in a subset of 1285 males and females, aged ≥40 years, who self-reported use (or non-use) of marijuana and tobacco cigarettes and performed spirometry before and after inhaled bronchodilator on multiple occasions. Analysis for the decline in FEV1was performed using random mixed effects regression models adjusted for age, sex and body mass index. Heavy tobacco smoking and marijunana smoking was defined as >20 pack-years and >20 joint-years, respectively.Results∼20% of participants had been or were current marijuana smokers with most having smoked tobacco cigarettes in addition (83%). Among heavy marijuana users, the risk of COPD was significantly increased (adjusted OR 2.45, 95% CI 1.55–3.88). Compared to never-smokers of marijuana and tobacco, heavy marijuana smokers and heavy tobacco smokers experienced a faster decline in FEV1by 29.5 mL·year−1(p=0.0007) and 21.1 mL·year−1(p<0.0001), respectively. Those who smoked both substances experienced a decline of 32.31 mL·year−1(p<0.0001).InterpretationHeavy marijuana smoking increases the risk of COPD and accelerates FEV1decline in concomitant tobacco smokers beyond that observed with tobacco alone.

Funder

Boehringer Ingelheim Canada Ltd

RI_MUHC Montreal

University of British Columbia

AstraZeneca Canada

the Respiratory Health Network of the FRSQ

Theratechnologies

Merck Nycomed

Canadian Respiratory Research Network

GlaxoSmithKline Canada Ltd

Almirall

Novartis

Pfizer Canada Ltd

Canadian Institutes of Health Research

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference39 articles.

1. World Health Organization. The Health and Social Effects of Nonmedical Cannabis Use. Geneva, World Health Organization, 2016. www.who.int/substance_abuse/publications/cannabis/en/ 2016

2. Marijuana use among adults 50 years or older in the 21st century;Lloyd;Gerontol Geriatr Med,2018

3. Centers for Disease Control and Prevention. 2017. Health Effects of Cigarette Smoking. www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm Date last updated: 17 January 2018.

4. Implications of marijuana decriminalization on the practice of pulmonary, critical care, and sleep medicine. a report of the American Thoracic Society Marijuana Workgroup;Douglas;Ann Am Thorac Soc,2015

5. Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis;Ghasemiesfe;Ann Intern Med,2018

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3